For patients with underlying immunodeficiency states: Scheduled intravenous immunoglobulin (which may reduce the frequency of lower respiratory infections [7]) For patients with cystic fibrosis: Antibiotics and inhaled bronchodilators as well as comprehensive support, and dietary supplementation.